Concorde International Group Ltd. (CIGL)
0.255
0.00 (0.00%)
USD |
NASDAQ |
Oct 16, 16:00
0.2255
-0.03
(-11.57%)
Pre-Market: 20:00
Concorde International Group R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
| Date | Value |
|---|
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.
R&D to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
R&D to Revenue (TTM) Benchmarks
| Securitas AB | -- |
| OIO Group | -- |
| Primech Holdings Ltd. | -- |
| YYForce, Inc. | -- |
| The Brink's Co. | -- |